| Revision as of 08:20, 3 January 2004 editMav (talk | contribs)Extended confirmed users77,874 editsm removed ugly inline, self-referential and alarming disclaimer; disclaimer already linked at bottom of every page← Previous edit | Revision as of 17:40, 5 January 2004 edit undoElBenevolente (talk | contribs)1,884 editsm Added Symbyax infoNext edit → | ||
| Line 1: | Line 1: | ||
| '''Olanzapine''' ('''Zyprexa<sup>®</sup>''') is one of the ] ] ]s. Olanzapine has been ] approved for treatment of ] and ] in ]. The ] ] ''Prozac Spotlight'' argues that a ] study demonstrated that the drug was ineffective in treatment of Parkinson's disease. | '''Olanzapine''' ('''Zyprexa<sup>®</sup>''', '''Symbyax<sup>®</sup>''') is one of the ] ] ]s. Olanzapine has been ] approved for treatment of ] and ] in ]. The ] ] ''Prozac Spotlight'' argues that a ] study demonstrated that the drug was ineffective in treatment of Parkinson's disease. | ||
| In December 2003 the ] approved '''Symbyax<sup>®</sup>''' to treat ] ]. '''Symbyax<sup>®</sup>''' is a combination of ] and ]. | |||
| ==Side Effects== | ==Side Effects== | ||
Revision as of 17:40, 5 January 2004
Olanzapine (Zyprexa, Symbyax) is one of the atypical antipsychotic medications. Olanzapine has been FDA approved for treatment of schizophrenia and mania in bipolar disorder. The anti-psychiatry website Prozac Spotlight argues that a 1999 study demonstrated that the drug was ineffective in treatment of Parkinson's disease.
In December 2003 the FDA approved Symbyax to treat bipolar depression. Symbyax is a combination of fluoxetine and olanzapine.
Side Effects
Common side effects include muscle-rigidity, muscle-stiffness, muscle-twitches, restlesness, sedation, and weight-gain. Olanzapine is reported to cause tardive dyskinesia and neurological malignant syndrome.
Olanzapine is manufactured by Eli Lilly (NYSE: LLY).